295 related articles for article (PubMed ID: 19337880)
1. Invasive mold infections: recent advances in management approaches.
Chandrasekar P
Leuk Lymphoma; 2009 May; 50(5):703-15. PubMed ID: 19337880
[TBL] [Abstract][Full Text] [Related]
2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
3. Current challenges in the management of invasive fungal infections.
Lai CC; Tan CK; Huang YT; Shao PL; Hsueh PR
J Infect Chemother; 2008 Apr; 14(2):77-85. PubMed ID: 18622668
[TBL] [Abstract][Full Text] [Related]
4. Changing epidemiology of rare mould infections: implications for therapy.
Malani AN; Kauffman CA
Drugs; 2007; 67(13):1803-12. PubMed ID: 17722951
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
6. Changing face of health-care associated fungal infections.
Bille J; Marchetti O; Calandra T
Curr Opin Infect Dis; 2005 Aug; 18(4):314-9. PubMed ID: 15985827
[TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. Fungal infections in leukemia patients: how do we prevent and treat them?
Leventakos K; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2010 Feb; 50(3):405-15. PubMed ID: 20047485
[TBL] [Abstract][Full Text] [Related]
9. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
10. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
Singh N
Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
[TBL] [Abstract][Full Text] [Related]
11. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
Bhatti Z; Shaukat A; Almyroudis NG; Segal BH
Mycopathologia; 2006 Jul; 162(1):1-15. PubMed ID: 16830186
[TBL] [Abstract][Full Text] [Related]
12. Current challenges in the diagnosis and management of invasive fungal infections: report from the 15th International Symposium on Infections in the Immunocompromised Host: Thessaloniki, Greece, 22-25 June 2008.
Groll AH; McNeil Grist L
Int J Antimicrob Agents; 2009 Feb; 33(2):101-4. PubMed ID: 19008080
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
14. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
15. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
Erjavec Z; Kluin-Nelemans H; Verweij PE
Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
[TBL] [Abstract][Full Text] [Related]
16. Current status of antifungal resistance and its impact on clinical practice.
Alcazar-Fuoli L; Mellado E
Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
[TBL] [Abstract][Full Text] [Related]
17. Mold Infections in Solid Organ Transplant Recipients.
Lemonovich TL
Infect Dis Clin North Am; 2018 Sep; 32(3):687-701. PubMed ID: 30146030
[TBL] [Abstract][Full Text] [Related]
18. Determination of MICs of aminocandin for Candida spp. and filamentous fungi.
Isham N; Ghannoum MA
J Clin Microbiol; 2006 Dec; 44(12):4342-4. PubMed ID: 17021057
[TBL] [Abstract][Full Text] [Related]
19. Invasive fungal infections: a review of epidemiology and management options.
Enoch DA; Ludlam HA; Brown NM
J Med Microbiol; 2006 Jul; 55(Pt 7):809-818. PubMed ID: 16772406
[TBL] [Abstract][Full Text] [Related]
20. Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections.
Lewis RE
Am J Ther; 2012 Jan; 19(1):51-63. PubMed ID: 21248618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
